Skip to content

Comparison of the effect of Sesamum indicum L. and medroxyprogestron on menstrual bleeding cessation

Comparison of the effect of Sesamum indicum L. and medroxyprogestron on oligomenorrhea: a Single blind randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013072014072N1
Enrollment
50
Registered
2013-12-21
Start date
2013-12-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oligomenorrhea. Secondary Oligomenorrhoea

Interventions

Intervention 1: Sesame seed product: 60 g daily for one week. Intervention 2: Medroxyprogesterone acetate 5 mg tablets BID for one week.
Treatment - Drugs
Sesame seed product: 60 g daily for one week
Medroxyprogesterone acetate 5 mg tablets BID for one week

Sponsors

Shahid Beheshty University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 20-40 y/o women; willing to participate in the study; cessation of menstrual bleeding for more than 14 days that has been repeated for at least 3 episodes during the last year; negative pregnancy test; not in lactation period; not affected by: diabetes, hypertension, organic disease and malignancies, chronic disease of the liver and kidneys; not using any kind of hormonal drugs(e.g. OCP) Exclusion criteria: Using hormonal drugs or any drug that will affect menstruation during the treatment period; patients willing to exit the study; patients that need invasive treatments during the study Exclusion criteria: Using hormonal drugs during the study experiencing drugs side effects patients who need interventions like surgery procedures those who will to exit the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Menstrual bleeding initiation. Timepoint: 2 weeks and 4 weeks after finishing the drug consumption. Method of measurement: interview.;Waiting period before menstrual bleeding. Timepoint: 2 weeks after finish the drug consumption. Method of measurement: interview.

Secondary

MeasureTime frame
Weight gain. Timepoint: during the study. Method of measurement: interview.;Hyrsutism. Timepoint: during the study. Method of measurement: interview.;Acne. Timepoint: during the study. Method of measurement: interview.;Nausia. Timepoint: during the study. Method of measurement: interview.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Maryam Yavari

Faculty of Traditional Medicine, Shahid Beheshty University of Medical Sciences

yavari@med.mui.ac.ir+98 21 8877 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026